The global Aminoglycosides Antibiotics revenue was US$ 1051.5 million in 2022 and is forecast to a readjusted size of US$ 1244.9 million by 2029 with a CAGR of 2.4% during the forecast period (2023-2029).

and India Aminoglycosides Antibiotics Market

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.

In India, the Aminoglycosides Antibiotics revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

The classification of Aminoglycosides Antibiotics includes Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin and Others. In addition, the proportion of Neomycin in 2019 is about 26%, and Etimicin mainly sales in China.

Aminoglycosides Antibiotics is widely used for Hospital, Clinic, Post Care Facility, Government & Military and Others. The most proportion of Aminoglycosides Antibiotics is for clinic, and the proportion in 2019 is about 35%.

Europe is the largest consumption place, with a consumption market share nearly 26% in 2019. Following Europe, China is the second largest consumption place with the consumption market share of about 16%.

Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma, Aike Pharmaceutical, Cipla, etc. are the leaders of the industry.

This report focuses on global and India Aminoglycosides Antibiotics market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Aminoglycosides Antibiotics will continue to grow rapidly in the future.

Global Aminoglycosides Antibiotics Scope and Market Size

Aminoglycosides Antibiotics market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Aminoglycosides Antibiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Aminoglycosides Antibiotics market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Aminoglycosides Antibiotics Market Report

Report Metric	Details
Report Name	and India Aminoglycosides Antibiotics Market
Forecasted market size in 2029	US$ 1244.9 million
CAGR	2.4%
Forecasted years	2023 - 2029
Segment by Type	Neomycin Tobramycin Gentamicin Amikacin Etimicin Others
Segment by Application	Hospital Clinic Post Care Facility Government & Military Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Aminoglycosides Antibiotics Market size in 2029?

Ans: The and India Aminoglycosides Antibiotics Market size in 2029 will be US$ 1244.9 million.

What is the and India Aminoglycosides Antibiotics Market share by application?

Ans: The most proportion of Aminoglycosides Antibiotics is for clinic, and the proportion in 2019 is about 35%.

What is the and India Aminoglycosides Antibiotics Market share by region?

Ans: Europe is the largest consumption place, with a consumption market share nearly 26% in 2019. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Aminoglycosides Antibiotics Market report?

Ans: The main players in the and India Aminoglycosides Antibiotics Market are Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company

What are the Application segmentation covered in the and India Aminoglycosides Antibiotics Market report?

Ans: The Applications covered in the and India Aminoglycosides Antibiotics Market report are Hospital, Clinic, Post Care Facility, Government & Military, Others

What are the Type segmentation covered in the and India Aminoglycosides Antibiotics Market report?

Ans: The Types covered in the and India Aminoglycosides Antibiotics Market report are Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin, Others

1 Study Coverage

1.1 Aminoglycosides Antibiotics Product Introduction

1.2 Global Aminoglycosides Antibiotics Outlook 2018 VS 2022 VS 2029

1.2.1 Global Aminoglycosides Antibiotics Sales in US$ Million for the Year 2018-2029

1.2.2 Global Aminoglycosides Antibiotics Sales in Volume for the Year 2018-2029

1.3 India Aminoglycosides Antibiotics Outlook 2018 VS 2022 VS 2029

1.3.1 India Aminoglycosides Antibiotics Sales in US$ Million for the Year 2018-2029

1.3.2 India Aminoglycosides Antibiotics Sales in Volume for the Year 2018-2029

1.4 Aminoglycosides Antibiotics Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Aminoglycosides Antibiotics in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Aminoglycosides Antibiotics Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Aminoglycosides Antibiotics Market Dynamics

1.5.1 Aminoglycosides Antibiotics Industry Trends

1.5.2 Aminoglycosides Antibiotics Market Drivers

1.5.3 Aminoglycosides Antibiotics Market Challenges

1.5.4 Aminoglycosides Antibiotics Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Aminoglycosides Antibiotics by Type

2.1 Aminoglycosides Antibiotics Market Segment by Type

2.1.1 Neomycin

2.1.2 Tobramycin

2.1.3 Gentamicin

2.1.4 Amikacin

2.1.5 Etimicin

2.1.6 Others

2.2 Global Aminoglycosides Antibiotics Market Size by Type

2.2.1 Global Aminoglycosides Antibiotics Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Aminoglycosides Antibiotics Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Aminoglycosides Antibiotics Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Aminoglycosides Antibiotics Market Size by Type

2.3.1 India Aminoglycosides Antibiotics Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Aminoglycosides Antibiotics Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Aminoglycosides Antibiotics Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Aminoglycosides Antibiotics by Application

3.1 Aminoglycosides Antibiotics Market Segment by Application

3.1.1 Hospital

3.1.2 Clinic

3.1.3 Post Care Facility

3.1.4 Government & Military

3.1.5 Others

3.2 Global Aminoglycosides Antibiotics Market Size by Application

3.2.1 Global Aminoglycosides Antibiotics Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Aminoglycosides Antibiotics Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Aminoglycosides Antibiotics Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Aminoglycosides Antibiotics Market Size by Application

3.3.1 India Aminoglycosides Antibiotics Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Aminoglycosides Antibiotics Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Aminoglycosides Antibiotics Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4 Global Aminoglycosides Antibiotics Competitor Landscape by Company

4.1 Global Aminoglycosides Antibiotics Market Size by Company

4.1.1 Global Key Manufacturers of Aminoglycosides Antibiotics, Ranked by Revenue (2022)

4.1.2 Global Aminoglycosides Antibiotics Revenue by Manufacturer (2018-2023)

4.1.3 Global Aminoglycosides Antibiotics Sales by Manufacturer (2018-2023)

4.1.4 Global Aminoglycosides Antibiotics Price by Manufacturer (2018-2023)

4.2 Global Aminoglycosides Antibiotics Concentration Ratio (CR)

4.2.1 Aminoglycosides Antibiotics Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Aminoglycosides Antibiotics in 2022

4.2.3 Global Aminoglycosides Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Aminoglycosides Antibiotics, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Aminoglycosides Antibiotics, Product Offered and Application

4.5 Global Key Manufacturers of Aminoglycosides Antibiotics, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Aminoglycosides Antibiotics Market Size by Company

4.7.1 Key Players of Aminoglycosides Antibiotics in India, Ranked by Revenue (2022)

4.7.2 India Aminoglycosides Antibiotics Revenue by Players (2018-2023)

4.7.3 India Aminoglycosides Antibiotics Sales by Players (2018-2023)

5 Global Aminoglycosides Antibiotics Market Size by Region

5.1 Global Aminoglycosides Antibiotics Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Aminoglycosides Antibiotics Market Size in Volume by Region (2018-2029)

5.2.1 Global Aminoglycosides Antibiotics Sales in Volume by Region: 2018-2023

5.2.2 Global Aminoglycosides Antibiotics Sales in Volume Forecast by Region (2024-2029)

5.3 Global Aminoglycosides Antibiotics Market Size in Value by Region (2018-2029)

5.3.1 Global Aminoglycosides Antibiotics Sales in Value by Region: 2018-2023

5.3.2 Global Aminoglycosides Antibiotics Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Aminoglycosides Antibiotics Market Size YoY Growth 2018-2029

6.2 Americas Aminoglycosides Antibiotics Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Aminoglycosides Antibiotics Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Aminoglycosides Antibiotics Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Aminoglycosides Antibiotics Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Aminoglycosides Antibiotics Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Aminoglycosides Antibiotics Market Size YoY Growth 2018-2029

7.2 EMEA Aminoglycosides Antibiotics Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Aminoglycosides Antibiotics Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Aminoglycosides Antibiotics Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Aminoglycosides Antibiotics Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Aminoglycosides Antibiotics Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Aminoglycosides Antibiotics Market Size YoY Growth 2018-2029

8.2 China Aminoglycosides Antibiotics Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Aminoglycosides Antibiotics Sales in Volume, by Application (2018, 2022 & 2029)

9 APAC

9.1 APAC Aminoglycosides Antibiotics Market Size YoY Growth 2018-2029

9.2 APAC Aminoglycosides Antibiotics Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Aminoglycosides Antibiotics Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Aminoglycosides Antibiotics Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Aminoglycosides Antibiotics Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Aminoglycosides Antibiotics Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Jemicare

10.1.1 Jemicare Company Information

10.1.2 Jemicare Description and Business Overview

10.1.3 Jemicare Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Jemicare Aminoglycosides Antibiotics Products Offered

10.1.5 Jemicare Recent Development

10.2 Teva

10.2.1 Teva Company Information

10.2.2 Teva Description and Business Overview

10.2.3 Teva Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Teva Aminoglycosides Antibiotics Products Offered

10.2.5 Teva Recent Development

10.3 Novartis

10.3.1 Novartis Company Information

10.3.2 Novartis Description and Business Overview

10.3.3 Novartis Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Novartis Aminoglycosides Antibiotics Products Offered

10.3.5 Novartis Recent Development

10.4 Fangyuan-pharma

10.4.1 Fangyuan-pharma Company Information

10.4.2 Fangyuan-pharma Description and Business Overview

10.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Fangyuan-pharma Aminoglycosides Antibiotics Products Offered

10.4.5 Fangyuan-pharma Recent Development

10.5 Aike Pharmaceutical

10.5.1 Aike Pharmaceutical Company Information

10.5.2 Aike Pharmaceutical Description and Business Overview

10.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Aike Pharmaceutical Aminoglycosides Antibiotics Products Offered

10.5.5 Aike Pharmaceutical Recent Development

10.6 Cipla

10.6.1 Cipla Company Information

10.6.2 Cipla Description and Business Overview

10.6.3 Cipla Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Cipla Aminoglycosides Antibiotics Products Offered

10.6.5 Cipla Recent Development

10.7 Pfizer

10.7.1 Pfizer Company Information

10.7.2 Pfizer Description and Business Overview

10.7.3 Pfizer Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Pfizer Aminoglycosides Antibiotics Products Offered

10.7.5 Pfizer Recent Development

10.8 Fresenius Kabi

10.8.1 Fresenius Kabi Company Information

10.8.2 Fresenius Kabi Description and Business Overview

10.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Fresenius Kabi Aminoglycosides Antibiotics Products Offered

10.8.5 Fresenius Kabi Recent Development

10.9 Sun Pharma

10.9.1 Sun Pharma Company Information

10.9.2 Sun Pharma Description and Business Overview

10.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Sun Pharma Aminoglycosides Antibiotics Products Offered

10.9.5 Sun Pharma Recent Development

10.10 Hikma

10.10.1 Hikma Company Information

10.10.2 Hikma Description and Business Overview

10.10.3 Hikma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Hikma Aminoglycosides Antibiotics Products Offered

10.10.5 Hikma Recent Development

10.11 Lannett Company

10.11.1 Lannett Company Company Information

10.11.2 Lannett Company Description and Business Overview

10.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2023)

10.11.4 Lannett Company Aminoglycosides Antibiotics Products Offered

10.11.5 Lannett Company Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Aminoglycosides Antibiotics Industry Chain Analysis

11.2 Aminoglycosides Antibiotics Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Aminoglycosides Antibiotics Production Mode & Process

11.4 Aminoglycosides Antibiotics Sales and Marketing

11.4.1 Aminoglycosides Antibiotics Sales Channels

11.4.2 Aminoglycosides Antibiotics Distributors

11.5 Aminoglycosides Antibiotics Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Aminoglycosides Antibiotics CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Aminoglycosides Antibiotics Market Trends

Table 3. Aminoglycosides Antibiotics Market Drivers

Table 4. Aminoglycosides Antibiotics Market Challenges

Table 5. Aminoglycosides Antibiotics Market Restraints

Table 6. Global Aminoglycosides Antibiotics Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Aminoglycosides Antibiotics Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Aminoglycosides Antibiotics Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Aminoglycosides Antibiotics Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Aminoglycosides Antibiotics, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Aminoglycosides Antibiotics Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Aminoglycosides Antibiotics Revenue Share by Manufacturer, 2018-2023

Table 13. Global Aminoglycosides Antibiotics Sales by Manufacturer, (M Units), 2018-2023

Table 14. Global Aminoglycosides Antibiotics Sales Share by Manufacturer, 2018-2023

Table 15. Global Aminoglycosides Antibiotics Price by Manufacturer (2018-2023) & (USD/Unit)

Table 16. Global Aminoglycosides Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Aminoglycosides Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics as of 2022)

Table 18. Global Key Manufacturers of Aminoglycosides Antibiotics, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Aminoglycosides Antibiotics, Product Offered and Application

Table 20. Global Key Manufacturers of Aminoglycosides Antibiotics, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Aminoglycosides Antibiotics in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Aminoglycosides Antibiotics Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Aminoglycosides Antibiotics Revenue Share by Players, (2018-2023)

Table 25. India Aminoglycosides Antibiotics Sales by Players, (M Units), (2018-2023)

Table 26. India Aminoglycosides Antibiotics Sales Share by Players, (2018-2023)

Table 27. Global Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Aminoglycosides Antibiotics Sales in Volume by Region (2018-2023) & (M Units)

Table 29. Global Aminoglycosides Antibiotics Sales in Volume Forecast by Region (2024-2029) & (M Units)

Table 30. Global Aminoglycosides Antibiotics Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Aminoglycosides Antibiotics Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Aminoglycosides Antibiotics Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Aminoglycosides Antibiotics Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Aminoglycosides Antibiotics Sales in Volume by Country (2018-2023) & (M Units)

Table 36. Americas Aminoglycosides Antibiotics Sales in Volume by Country (2024-2029) & (M Units)

Table 37. EMEA Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Aminoglycosides Antibiotics Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Aminoglycosides Antibiotics Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Aminoglycosides Antibiotics Sales in Volume by Country (2018-2023) & (M Units)

Table 41. EMEA Aminoglycosides Antibiotics Sales in Volume by Country (2024-2029) & (M Units)

Table 42. APAC Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Aminoglycosides Antibiotics Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Aminoglycosides Antibiotics Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Aminoglycosides Antibiotics Sales in Volume by Country (2018-2023) & (M Units)

Table 46. APAC Aminoglycosides Antibiotics Sales in Volume by Country (2024-2029) & (M Units)

Table 47. Jemicare Company Information

Table 48. Jemicare Description and Business Overview

Table 49. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 50. Jemicare Aminoglycosides Antibiotics Product

Table 51. Jemicare Recent Development

Table 52. Teva Company Information

Table 53. Teva Description and Business Overview

Table 54. Teva Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 55. Teva Aminoglycosides Antibiotics Product

Table 56. Teva Recent Development

Table 57. Novartis Company Information

Table 58. Novartis Description and Business Overview

Table 59. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 60. Novartis Aminoglycosides Antibiotics Product

Table 61. Novartis Recent Development

Table 62. Fangyuan-pharma Company Information

Table 63. Fangyuan-pharma Description and Business Overview

Table 64. Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 65. Fangyuan-pharma Aminoglycosides Antibiotics Product

Table 66. Fangyuan-pharma Recent Development

Table 67. Aike Pharmaceutical Company Information

Table 68. Aike Pharmaceutical Description and Business Overview

Table 69. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 70. Aike Pharmaceutical Aminoglycosides Antibiotics Product

Table 71. Aike Pharmaceutical Recent Development

Table 72. Cipla Company Information

Table 73. Cipla Description and Business Overview

Table 74. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 75. Cipla Aminoglycosides Antibiotics Product

Table 76. Cipla Recent Development

Table 77. Pfizer Company Information

Table 78. Pfizer Description and Business Overview

Table 79. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 80. Pfizer Aminoglycosides Antibiotics Product

Table 81. Pfizer Recent Development

Table 82. Fresenius Kabi Company Information

Table 83. Fresenius Kabi Description and Business Overview

Table 84. Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 85. Fresenius Kabi Aminoglycosides Antibiotics Product

Table 86. Fresenius Kabi Recent Development

Table 87. Sun Pharma Company Information

Table 88. Sun Pharma Description and Business Overview

Table 89. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 90. Sun Pharma Aminoglycosides Antibiotics Product

Table 91. Sun Pharma Recent Development

Table 92. Hikma Company Information

Table 93. Hikma Description and Business Overview

Table 94. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 95. Hikma Aminoglycosides Antibiotics Product

Table 96. Hikma Recent Development

Table 97. Lannett Company Company Information

Table 98. Lannett Company Description and Business Overview

Table 99. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 100. Lannett Company Aminoglycosides Antibiotics Product

Table 101. Lannett Company Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Aminoglycosides Antibiotics Customers List

Table 105. Aminoglycosides Antibiotics Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Aminoglycosides Antibiotics Product Picture

Figure 2. Global Aminoglycosides Antibiotics Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Aminoglycosides Antibiotics Market Size 2018-2029 (US$ Million)

Figure 4. Global Aminoglycosides Antibiotics Sales 2018-2029 (M Units)

Figure 5. India Aminoglycosides Antibiotics Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Aminoglycosides Antibiotics Market Size 2018-2029 (US$ Million)

Figure 7. India Aminoglycosides Antibiotics Sales 2018-2029 (M Units)

Figure 8. India Aminoglycosides Antibiotics Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Aminoglycosides Antibiotics Market Share in Global, in Volume (M Units) 2018-2029

Figure 10. Aminoglycosides Antibiotics Report Years Considered

Figure 11. Product Picture of Neomycin

Figure 12. Product Picture of Tobramycin

Figure 13. Product Picture of Gentamicin

Figure 14. Product Picture of Amikacin

Figure 15. Product Picture of Etimicin

Figure 16. Product Picture of Others

Figure 17. Global Aminoglycosides Antibiotics Market Share by Type in 2022 & 2029

Figure 18. Global Aminoglycosides Antibiotics Sales in Value by Type (2018-2029) & (US$ Million)

Figure 19. Global Aminoglycosides Antibiotics Sales Market Share in Value by Type (2018-2029)

Figure 20. Global Aminoglycosides Antibiotics Sales by Type (2018-2029) & (M Units)

Figure 21. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Type (2018-2029)

Figure 22. Global Aminoglycosides Antibiotics Price by Type (2018-2029) & (USD/Unit)

Figure 23. India Aminoglycosides Antibiotics Market Share by Type in 2022 & 2029

Figure 24. India Aminoglycosides Antibiotics Sales in Value by Type (2018-2029) & (US$ Million)

Figure 25. India Aminoglycosides Antibiotics Sales Market Share in Value by Type (2018-2029)

Figure 26. India Aminoglycosides Antibiotics Sales by Type (2018-2029) & (M Units)

Figure 27. India Aminoglycosides Antibiotics Sales Market Share in Volume by Type (2018-2029)

Figure 28. India Aminoglycosides Antibiotics Price by Type (2018-2029) & (USD/Unit)

Figure 29. Product Picture of Hospital

Figure 30. Product Picture of Clinic

Figure 31. Product Picture of Post Care Facility

Figure 32. Product Picture of Government & Military

Figure 33. Product Picture of Others

Figure 34. Global Aminoglycosides Antibiotics Market Share by Application in 2022 & 2029

Figure 35. Global Aminoglycosides Antibiotics Sales in Value by Application (2018-2029) & (US$ Million)

Figure 36. Global Aminoglycosides Antibiotics Sales Market Share in Value by Application (2018-2029)

Figure 37. Global Aminoglycosides Antibiotics Sales by Application (2018-2029) & (M Units)

Figure 38. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Application (2018-2029)

Figure 39. Global Aminoglycosides Antibiotics Price by Application (2018-2029) & (USD/Unit)

Figure 40. India Aminoglycosides Antibiotics Market Share by Application in 2022 & 2029

Figure 41. India Aminoglycosides Antibiotics Sales in Value by Application (2018-2029) & (US$ Million)

Figure 42. India Aminoglycosides Antibiotics Sales Market Share in Value by Application (2018-2029)

Figure 43. India Aminoglycosides Antibiotics Sales by Application (2018-2029) & (M Units)

Figure 44. India Aminoglycosides Antibiotics Sales Market Share in Volume by Application (2018-2029)

Figure 45. India Aminoglycosides Antibiotics Price by Application (2018-2029) & (USD/Unit)

Figure 46. Americas Aminoglycosides Antibiotics Sales in Volume Growth Rate 2018-2029 (M Units)

Figure 47. Americas Aminoglycosides Antibiotics Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 48. Americas Aminoglycosides Antibiotics Sales by Type (2018-2029) & (M Units)

Figure 49. Americas Aminoglycosides Antibiotics Sales Market Share in Volume by Type (2018-2029)

Figure 50. Americas Aminoglycosides Antibiotics Sales by Application (2018-2029) & (M Units)

Figure 51. Americas Aminoglycosides Antibiotics Sales Market Share in Volume by Application (2018-2029)

Figure 52. United States Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 53. Canada Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 54. Mexico Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 55. Brazil Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 56. EMEA Aminoglycosides Antibiotics Sales in Volume Growth Rate 2018-2029 (M Units)

Figure 57. EMEA Aminoglycosides Antibiotics Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 58. EMEA Aminoglycosides Antibiotics Sales by Type (2018-2029) & (M Units)

Figure 59. EMEA Aminoglycosides Antibiotics Sales Market Share in Volume by Type (2018-2029)

Figure 60. EMEA Aminoglycosides Antibiotics Sales by Application (2018-2029) & (M Units)

Figure 61. EMEA Aminoglycosides Antibiotics Sales Market Share in Volume by Application (2018-2029)

Figure 62. Europe Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 63. Middle East Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 64. Africa Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 65. China Aminoglycosides Antibiotics Sales in Volume Growth Rate 2018-2029 (M Units)

Figure 66. China Aminoglycosides Antibiotics Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 67. China Aminoglycosides Antibiotics Sales by Type (2018-2029) & (M Units)

Figure 68. China Aminoglycosides Antibiotics Sales Market Share in Volume by Type (2018-2029)

Figure 69. China Aminoglycosides Antibiotics Sales by Application (2018-2029) & (M Units)

Figure 70. China Aminoglycosides Antibiotics Sales Market Share in Volume by Application (2018-2029)

Figure 71. APAC Aminoglycosides Antibiotics Sales in Volume Growth Rate 2018-2029 (M Units)

Figure 72. APAC Aminoglycosides Antibiotics Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 73. APAC Aminoglycosides Antibiotics Sales by Type (2018-2029) & (M Units)

Figure 74. APAC Aminoglycosides Antibiotics Sales Market Share in Volume by Type (2018-2029)

Figure 75. APAC Aminoglycosides Antibiotics Sales by Application (2018-2029) & (M Units)

Figure 76. APAC Aminoglycosides Antibiotics Sales Market Share in Volume by Application (2018-2029)

Figure 77. Japan Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 78. South Korea Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 79. China Taiwan Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 80. Southeast Asia Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 81. India Aminoglycosides Antibiotics Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 82. Aminoglycosides Antibiotics Value Chain

Figure 83. Aminoglycosides Antibiotics Production Process

Figure 84. Channels of Distribution

Figure 85. Distributors Profiles

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions